跳轉至內容
Merck
  • Impaired liver function in Xenopus tropicalis exposed to benzo[a]pyrene: transcriptomic and metabolic evidence.

Impaired liver function in Xenopus tropicalis exposed to benzo[a]pyrene: transcriptomic and metabolic evidence.

BMC genomics (2014-08-12)
Christophe Regnault, Isabelle A M Worms, Christine Oger-Desfeux, Christelle MelodeLima, Sylvie Veyrenc, Marie-Laure Bayle, Bruno Combourieu, Aurélie Bonin, Julien Renaud, Muriel Raveton, Stéphane Reynaud
摘要

Despite numerous studies suggesting that amphibians are highly sensitive to cumulative anthropogenic stresses, the role pollutants play in the decline of amphibian populations remains unclear. Amongst the most common aquatic contaminants, polycyclic aromatic hydrocarbons (PAHs) have been shown to induce several adverse effects on amphibian species in the larval stages. Conversely, adults exposed to high concentrations of the ubiquitous PAH, benzo[a]pyrene (BaP), tolerate the compound thanks to their highly efficient hepatic detoxification mechanisms. Due to this apparent lack of toxic effect on adults, no studies have examined in depth the potential toxicological impact of PAH on the physiology of adult amphibian livers. This study sheds light on the hepatic responses of Xenopus tropicalis when exposed to high environmentally relevant concentrations of BaP, by combining a high throughput transcriptomic approach (mRNA deep sequencing) and a characterization of cellular and physiological modifications to the amphibian liver. Transcriptomic changes observed in BaP-exposed Xenopus were further characterized using a time-dependent enrichment analysis, which revealed the pollutant-dependent gene regulation of important biochemical pathways, such as cholesterol biosynthesis, insulin signaling, adipocytokines signaling, glycolysis/gluconeogenesis and MAPK signaling. These results were substantiated at the physiological level with the detection of a pronounced metabolic disorder resulting in a possible insulin resistance-like syndrome phenotype. Hepatotoxicity induced by lipid and cholesterol metabolism impairments was clearly identified in BaP-exposed individuals. Our data suggested that BaP may disrupt overall liver physiology, and carbohydrate and cholesterol metabolism in particular, even after short-term exposure. These results are further discussed in terms of how this deregulation of liver physiology can lead to general metabolic impairment in amphibians chronically exposed to contaminants, thereby illustrating the role xenobiotics might play in the global decline in amphibian populations.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
甲醇, suitable for HPLC, ≥99.9%
Sigma-Aldrich
甲醇, ACS reagent, ≥99.8%
Sigma-Aldrich
甲醇, suitable for HPLC, gradient grade, ≥99.9%
Sigma-Aldrich
甲醇, HPLC Plus, ≥99.9%
Sigma-Aldrich
甲醇, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., ≥99.8% (GC)
Supelco
N,O-双(三甲基硅)三氟乙酰胺(含三甲基氯硅烷), with 1% trimethylchlorosilane, for GC derivatization, LiChropur
Sigma-Aldrich
甲醇, Laboratory Reagent, ≥99.6%
Sigma-Aldrich
甲醇, ACS spectrophotometric grade, ≥99.9%
Sigma-Aldrich
甲醇, Absolute - Acetone free
Sigma-Aldrich
5α-胆甾烷溶液, ≥97.0% (HPLC)
Sigma-Aldrich
甲醇, BioReagent, ≥99.93%
Sigma-Aldrich
N,O-双(三甲基硅基)三氟乙酰胺, ≥99%
Sigma-Aldrich
甲醇, ACS reagent, ≥99.8%
USP
木精, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
甲醇, ACS reagent, ≥99.8%
Sigma-Aldrich
甲醇, anhydrous, 99.8%
Sigma-Aldrich
甲醇, puriss., meets analytical specification of Ph Eur, ≥99.7% (GC)
Supelco
N,O-双(三甲基硅)三氟乙酰胺(含三甲基氯硅烷), for GC derivatization, LiChropur, contains 1% TMCS, 99% (excluding TMCS)
Supelco
甲醇, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
N,O-双(三甲基硅基)三氟乙酰胺, for GC derivatization, LiChropur, ≥99.0%
Supelco
甲醇, analytical standard
Sigma-Aldrich
甲醇, NMR reference standard
Sigma-Aldrich
甲醇-12C, 99.95 atom % 12C
Supelco
N,O-双(三甲基硅)三氟乙酰胺(含三甲基氯硅烷), for GC derivatization, LiChropur, contains 10% TMCS, 98% (excluding TMCS)
Sigma-Aldrich
甲醇, HPLC Plus, ≥99.9%, poly-coated bottles
Supelco
异丙甲草胺 草酸盐, PESTANAL®, analytical standard